CDIBA
CDIBA is a cytosolic phospholipase A2 (cPLA2) inhibitor. CDIBA inhibits the activation of cPLA2 in rat diaphragm tissue. CDIBA reduces the level of mitochondrial reactive oxygen species in rat diaphragm tissue after prolonged mechanical ventilation. CDIBA attenuates protein degradation, muscle atrophy and decreased muscle strength in the diaphragm of rats after prolonged mechanical ventilation. CDIBA can be used in studies related to ventilator-induced diaphragmatic dysfunction.
For research use only. We do not sell to patients.
- CAS No.: 479422-22-5
- Formula: C31H26ClNO3
- Molecular Weight:496.00
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Phospholipase Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MC9 | Inhibition |
-8 %
Compound: 25
|
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
81 %
Compound: 25
|
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
96 %
Compound: 25
|
Inhibition of LTB4 production in MC9 cells at 1.5 uM
Inhibition of LTB4 production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats (adult male, SPF level, 450-550 g, ventilator-induced diaphragm dysfunction model)[1]
-
Dosage:30 mg/kg (i.p. injection); 5 mg/kg/h (continuous i.v. infusion)
-
Administration:i.p. (single injection at ventilation onset); i.v. (continuous infusion; 12 hours)
-
Result:Significantly reduced cPLA2 activation in the diaphragm.
Decreased mitochondrial H2O2 production in the diaphragm.
Downregulated diaphragm calpain activity.
Reduced the expression of atrophy-related genes Atrogin-1 and MuRF-1 in the diaphragm.
Increased the cross-sectional area of slow-twitch and fast-twitch diaphragm muscle fibers.
Improved diaphragm contractile function, including increased maximal tetanic forces, elevated force-frequency curve responses, and enhanced fatigue tolerance, compared to untreated ventilated rats.
Chemical Information
-
CAS No. 479422-22-5
-
Molecular Weight 496.00
-
Formula C31H26ClNO3
-
SMILES
O=C(O)C1=CC=C(OCCC=2C=3C=C(Cl)C=CC3N(C2C)C(C=4C=CC=CC4)C=5C=CC=CC5)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- CDIBA
- 479422-22-5
- Phospholipase
- Reactive Oxygen Species (ROS)
- mitochondrial reactive oxygen species
- cytosolic phospholipase A2
- protein degradation
- prolonged mechanical ventilation
- calpain activity
- rat diaphragm tissue
- diaphragm contractile force
- ventilator-induced diaphragm dysfunction
- muscle atrophy
- Inhibitor
- inhibitor
- inhibit